March 19, 2026

🎙️We are proud to be featured in the latest episode of L’Écho Santé by Medicen Paris Region, highlighting the crucial role of public–private partnerships in advancing health innovation.
 
At 34:56, François Ballet — President of the Project Evaluation Committee at Medicen Paris Region — describes Cardiawave as “a unique technology in the world,” developed in “a field where France is a leader in ultrasound,” and as “a story with a promising future.” These words strongly resonate with our mission and with the collaborative effort behind our work.
 
This recognition comes at a key moment for us: Valvosoft® is now CE‑marked, confirming the safety and performance of our non‑invasive ultrasound therapy for aortic stenosis — and opening the way for its next steps toward clinical adoption. 💙💡
 
Our progress is the result of a long‑standing and exceptional partnership with AP‑HP, Assistance Publique – Hôpitaux de Paris, in particular HEGP, and with leading academic institutions such as Physics for Medicine Paris, Institut Langevin, CNRS, ESPCI Paris – PSL, Inserm, and the RHU_STOP_AS consortium.
 
A warm thank you to Medicen Paris Region for this highlight, as well as to:
 
🎤 François Ballet – President of the Project Evaluation Committee, Medicen Paris Region
🎤 Nicolas Castoldi – Deputy Director for Transformation, @AP‑HP
🎙️ Marguerite de Rodellec – Host & Co‑founder, MedShake Studio
 
▶️ Watch the full episode:
https://youtu.be/uhp1Nvk-igw?si=MJ8wRhPIobXseHMD
 
#MedTech #StructuralHeart #Innovation #AorticStenosis #CardiovascularInnovation #Valvosoft #medtech #focusedultrasound #innovation #NIUT #TAVI #TAVR #AorticValve #lifetimemanagementofas #valves #CEMarking
#FrenchCare #Health20 @france-biotech @medicen-paris-region @bpi-france @focusedultrasoundfoundation @eic-scalingclub @snitem